NavioMD Tirzepatide Review: Prices, Care and Cancellation

NavioMD advertises compounded tirzepatide as low as $189 per month and also lists a Zepbound pathway. The entry headline does not establish your selected dose, plan or ongoing payment. Its public pages give differing descriptions of price changes and state coverage, so confirm both before paying.^3,4,8

The useful distinction is that NavioMD names a clinical-services partner and pharmacy partner. Those disclosures help identify the care chain, but they do not replace the actual prescription, financial agreement or location check.

What does the $189 headline include?

The compounded-tirzepatide product page displays $189 alongside $299, requires full upfront payment and says the final price depends on the chosen product and subscription plan. It says starting doses include nausea support, B12 and a virtual provider visit when appropriate. It does not establish a complete dose-by-dose schedule or a maximum ongoing charge.³

The homepage describes dose-tier pricing. The product's pricing FAQ instead describes an inclusive price covering the provider visit, prescribed medication and necessary supplies, with the price staying the same month after month. Request the applicable dose and refill schedule in writing. Neither statement should be expanded into a universal guarantee for every plan.^3,4

Ask whether a care membership is optional, its separate cost if selected, and what happens when it is canceled. Do not assume that a care-service subscription includes medication or that a starting product amount includes every future visit, laboratory test or prescription change.

Clinical access and state coverage differ

The homepage says NavioMD serves all 50 states. Its telehealth consent identifies Qualiphy as the clinical partner but still says telehealth care is unsupported in Alabama and Mississippi. Pharmacy shipping coverage and clinician eligibility are separate questions. Confirm your physical location, treatment and assigned clinician before authorizing payment.^4,5

The consent describes video, phone, messaging, intake review and asynchronous evaluation where allowed. It says providers make independent clinical decisions and may determine that remote care is unsuitable. The homepage offers provider messaging; obtain the contact route, response expectation and follow-up plan for side effects, dose decisions and refill review.^4,5

The named pharmacy and delivery conditions

NavioMD's About page names The Pharmacy Hub as its exclusive 503A pharmacy partner; the consent also identifies it for fulfillment. This is a provider disclosure, not independent verification of the dispensing facility, license or a particular preparation. Ask for the facility actually filling your prescription and its pharmacist contact information.^5,6

The product advertises free two-day shipping subject to a visit before 4 p.m. Eastern, with later orders shipping the next business day. Medical approval and order processing come first. Confirm the actual dispatch date, weekend handling, storage instructions and procedure for delivery problems; a shipping speed is not a guaranteed interval from starting the questionnaire.³

Get the financial agreement before the charge

The consent permits canceling a membership through the patient portal and withdrawing telehealth consent. It also says withdrawal does not undo services rendered, prescriptions issued or charges already incurred. That does not establish a full medication-refund policy.⁵

The footer's Terms of Service destination presents a Privacy Policy headed as such. That page identifies NavioMD Inc., but it does not supply the selected treatment's renewal, pharmacy-processing cancellation or unused-prepayment rules. Obtain those terms, including any medical-ineligibility refund and retained consultation fee, before payment.⁷

Compare the actual prescribed product

The current menu includes Zepbound alongside compounded tirzepatide. Brand availability and final price still depend on the selected product and clinical approval; do not treat an older Ozempic or Mounjaro quote as today's offer.^4,8 Compare Mint Med using the full bill and exit conditions, rather than assuming every compounded plan has the same economics.

Compounded preparations are not FDA-approved finished drugs. Trials of branded tirzepatide do not establish the safety or effectiveness of every compounded formulation.^1,2 Read the compounding guide and evidence guide, and discuss side effects, gallbladder concerns and the thyroid warning with your clinician.

See the provider comparison for wider context. This review uses public information without treatment or a purchase.